HeartSciences Inc.
HSCS
$3.70
$0.010.27%
NASDAQ
07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 3.22% | 19.20% | 30.45% | -3.55% | 11.20% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -9.62% | 2.39% | 53.98% | 26.13% | 55.99% |
Operating Income | 9.71% | -2.16% | -55.47% | -26.44% | -55.99% |
Income Before Tax | -0.16% | -13.44% | -54.29% | -19.13% | -50.10% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -0.16% | -13.44% | -54.29% | -19.13% | -50.10% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -0.16% | -13.44% | -54.29% | -19.13% | -50.10% |
EBIT | 9.71% | -2.16% | -55.47% | -26.44% | -55.99% |
EBITDA | 9.54% | -2.26% | -55.45% | -26.28% | -55.96% |
EPS Basic | 40.24% | 30.86% | 14.46% | 85.74% | 80.06% |
Normalized Basic EPS | 40.24% | 30.87% | 14.46% | 85.74% | 80.06% |
EPS Diluted | 40.24% | 30.86% | 14.46% | 85.74% | 80.06% |
Normalized Diluted EPS | 40.24% | 30.87% | 14.46% | 85.74% | 80.06% |
Average Basic Shares Outstanding | 67.61% | 64.10% | 80.37% | 735.52% | 652.86% |
Average Diluted Shares Outstanding | 67.61% | 64.10% | 80.37% | 735.52% | 652.86% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |